Tvardi Therapeutics Inc. (TVRD) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Tvardi Therapeutics Inc.

    NASDAQ: TVRD · Real-Time Price · USD
    40.23
    2.86 (7.65%)
    At close: Oct 03, 2025, 3:59 PM
    40.55
    0.80%
    After-hours: Oct 03, 2025, 04:21 PM EDT

    Tvardi Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -70.87M -17.35M -20.54M -88.44M
    Depreciation & Amortization
    		 192K 95K 85K 1.55M
    Stock-Based Compensation
    		 n/a 314K 246K n/a
    Other Working Capital
    		 5.36M -3.96M 2.67M 7.96M
    Other Non-Cash Items
    		 24.86M -143K -321K 21.54M
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 -15.1M -3.96M 2.67M 5.26M
    Operating Cash Flow
    		 -60.92M -21.04M -17.87M -60.09M
    Capital Expenditures
    		 -1.05M -2.38M -50K -39K
    Cash Acquisitions
    		 n/a n/a n/a 70K
    Purchase of Investments
    		 -32.21M -113.61M -43.99M -208.79M
    Sales Maturities Of Investments
    		 82M 22.47M 22.05M 204.01M
    Other Investing Acitivies
    		 n/a 115.98M n/a n/a
    Investing Cash Flow
    		 48.74M 22.47M -22M -4.75M
    Debt Repayment
    		 -3.6M 36.47M n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 n/a -36.47M n/a n/a
    Financial Cash Flow
    		 -3.6M 2K 4K 46.61M
    Net Cash Flow
    		 -14.28M 1.43M -39.86M -18.23M
    Free Cash Flow
    		 -61.96M -21.04M -17.92M -60.13M

    Add to Watchlist